Table 4

Other clinical outcomes from randomisation until last known date of follow-up

CTO-PCI (n=148)CTO-No PCI (n=154)HR (95% CI)Log-rank P value
All-cause death14 (12∙9%)7 (6∙2%)2.07 (0∙84 to 5∙14)0∙11
Any repeat PCI32 (25∙7%)42 (29∙3%)0∙74 (0∙46 to 1∙16)0∙19
Target lesion PCI*13 (9.9%)36 (25.5%)
Total stent thrombosis (definite/probable)6 (4∙1%)6 (4∙1%) 0∙95
  Stent thrombosis CTO lesion41
  Definite21
  Probable20
  Timing of stent thrombosis
  Acute00
  Subacute30
  Late00
  Very late11
Stent thrombosis non-CTO lesion66
  Definite46
  Probable20
Timing of stent thrombosis
  Acute01
  Subacute52
  Late00
  Very late13
Stroke2 (1∙5%)4 (2∙9%)0∙28
Bleeding according to GUSTO criteria8 (5∙5%)5 (3∙3%)0∙34
  Mild23
  Moderate51
  Severe or life threatening11
  • Adjudicated clinical outcomes from randomisation to long-term follow-up. Data are numbers of patients with percentages. KM estimates from the Kaplan-Meier curves.

  • *The target lesion is defined as the CTO lesion.

  • CTO, chronic total occlusion; GUSTO, global use of strategies to open occluded coronary arteries; PCI, percutaneous coronary intervention, TLR, target lesion revascularisation.